News
5 May 2026
arcoris bio launches immunoMUSE®, enabling flexible, high-sensitivity multiplex immunofluorescence with user-defined antibodies
20 January 2026
Launching an Early Adopter Program — Apply now to join us to Shape What’s Next
6 November 2025
arcoris bio raises CHF 6.3 million seed round to advance next- generation biomarker technology for digital pathology